期刊文献+

趋化因子及其受体对卵巢癌发生发展的作用的研究进展 被引量:2

Research Progress on the Role of Chemokines and Their Receptors in the Development of Ovarian Cancer
下载PDF
导出
摘要 卵巢癌是常见的生殖系统恶性肿瘤之一,由于卵巢癌发病早期多无症状,死亡率占各类妇科肿瘤之首。因此,寻找早期诊断卵巢癌的标志物意义重大。趋化因子是一类炎症介质,它们能够在多种肿瘤发生发展过程中发挥重要作用。本篇综述报道了趋化因子对卵巢癌发生发展的作用的研究进展。 Ovarian cancer is one of the common malignant tumors of the reproductive system.Because ovarian cancer is mostly asymptomatic in the early stages,the mortality rate is the highest in all types of gynecological tumors.Therefore,it is of great significance to find markers for early diagnosis of ovarian cancer.Chemokines are a class of inflammatory mediators,and they can play an important role in the development of many tumors.This review reports the research progress on the role of chemokines in the development of ovarian cancer.
作者 向雨 张泽宇 辛华 Xiang Yu;Zhang Zeyu;Xin Hua(First Affiliated Hospital,Jiamusi University,Jiamusi 154007,China)
出处 《广东化工》 CAS 2020年第9期129-130,共2页 Guangdong Chemical Industry
关键词 卵巢癌 趋化因子 肿瘤标志物 ovarian cancer chemokine tumor markers
  • 相关文献

参考文献1

二级参考文献8

  • 1王琪,李力,黎丹戎,张伟,韦霄,张洁清,唐勇.应用飞行时间质谱技术结合蛋白芯片筛选卵巢恶性肿瘤患者的血清标志物[J].中华妇产科杂志,2006,41(8):544-548. 被引量:33
  • 2吴江宏,王亚农,欧周罗,师英强.胃癌患者术前外周血CCL18的检测及其意义[J].中国癌症杂志,2006,16(10):835-837. 被引量:9
  • 3Judith YMNE, Marie-Chrlstine WG, Jan HMS, et al. Clinical proteomics: searching for better turnout markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci, 2006, 27: 251-259.
  • 4Zhang Z, Bast BC, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res, 2004, 15: 5882-5890.
  • 5Kodera M, Hasegawa M, Komura K, et al. Serum pulmonary and activation regulated chemokine /CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis. Arthritis Rheum, 2005, 52 : 2889-2896.
  • 6StruyfS, Schutyser E, Gouwy M, et al. CCL18 /CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia. Am J Pathol, 2003, 163 : 2065-2075.
  • 7Leung SY, Yuen ST, Chu KM, et al. Expression profiling identifies chemokine (C2C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology, 2004, 127 : 457-469.
  • 8Schutyser E, Struyf S, Proost P, et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18 /pulmonary and activation2regulated chemokine in ovarian carcinoma. J Biol Chem, 2002, 277: 245842-24593.

共引文献9

同被引文献28

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部